Publications by authors named "Chengjun Sui"

Claim this Profile
A
APOA2 mediates immune therapy tolerance in hepatocellular carcinoma by inhibiting the antigen-presenting function of dendritic cells through the PPAR signaling pathway.
Junwu Guo, Binghua Dai, Hengmei Zhu, Chengjun Sui, Zhitao Dong

Transl Cancer Res· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TM4SF1 overexpression in tumor-associated endothelial cells promotes microvascular invasion in hepatocellular carcinoma.
Junwu Guo, Liangrui Chen, Binghua Dai, Chengjun Sui, Zhitao Dong

Front Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deciphering the Multifaceted Immune Landscape of Unresectable Primary Liver Cancer to Predict Immunotherapy Response.
Jun Xue, Shuai Yang, Si-Si Zhang, Jun Fan, Zi-Long Wu, Cheng-Jun Sui

Adv Sci (Weinh)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of SPP1 macrophages in promoting cancer stemness via vitronectin and CCL15 signals crosstalk in liver cancer.
Yizhou Wang, Qing Wang, Shuangfen Tao, Haoyu Li, Xiaofeng Zhang, Chengjun Sui

Cancer Lett· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy combined with lenvatinib and PD-1 may be a potential better alternative option for advanced unresectable intrahepatic cholangiocarcinoma: a retrospective real-world study.
Zhitao Dong, Chengjun Sui, Jiongjiong Lu, Junwu Guo, Kecai Duan

Front Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression Characteristics, Immune Signature, and Prognostic Value of the SOCS Family Identified by Multiomics Integrative Analysis in Liver Cancer.
Zhitao Dong, Binghua Dai, Rui Wu, Kunpeng Fang, Chengjun Sui

Cancer Rep (Hoboken)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel genetic alterations in liver cancer distinguish distinct clinical outcomes and combination immunotherapy responses.
Yizhou Wang, Peipei Shang, Chang Xu, Wei Dong, Xiaofeng Zhang, Chengjun Sui

Front Pharmacol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TFAIP6 facilitates hepatocellular carcinoma cell glycolysis through upregulating c-myc/PKM2 axis.
Kecai Duan, Kunpeng Fang, Chengjun Sui

Heliyon· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gastrointestinal perforation associated with bevacizumab in metastatic colorectal cancer.
Kunpeng Fang, Jie Wang, Jianyong Yuan, Chengjun Sui, Jiajun Zhi

Cancer Rep (Hoboken)· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to letter entitled: Re: 'Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with micro-vascular invasion: A randomized controlled trial'.
Changying Shi, Yong Li, Li Geng, Weifeng Shen, Chengjun Sui

Eur J Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The surgical outcomes and risk factors of giant hepatic haemangiomas: a single centre experience.
Zhitao Dong, Kunpeng Fang, Chengjun Sui, Junwu Guo, Binghua Dai

BMC Surg· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adjuvant stereotactic body radiotherapy after marginal resection for hepatocellular carcinoma with microvascular invasion: A randomised controlled trial.
Changying Shi, Yong Li, Li Geng, Weifeng Shen, Chengjun Sui

Eur J Cancer· May 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of metformin use on risk and mortality of hepatocellular carcinoma in diabetes mellitus.
Qiaomei Li, Hairong Xu, Chengjun Sui, Hongjuan Zhang

Clin Res Hepatol Gastroenterol· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of a Carbamoyl Phosphate Synthetase 1-Deficient HCC Subtype With Therapeutic Potential Through Integrative Genomic and Experimental Analysis.
Tong Wu, Guijuan Luo, Qiuyu Lian, Chengjun Sui, Jing Tang

Hepatology· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comprehensive analysis of spatial architecture in primary liver cancer.
Rui Wu, Wenbo Guo, Xinyao Qiu, Shicheng Wang, Chengjun Sui

Sci Adv· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A combined Cox and logistic model provides accurate predictive performance in estimation of time-dependent probabilities for recurrence of intrahepatic cholangiocarcinoma after resection.
Seogsong Jeong, Guijuan Luo, Qiang Gao, Jing Chen, Xiaolong Liu, Chengjun Sui

Hepatobiliary Surg Nutr· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted sequencing reveals the mutational landscape responsible for sorafenib therapy in advanced hepatocellular carcinoma.
Jing Tang, Cheng-Jun Sui, Dong-Fang Wang, Xin-Yuan Lu, Gui-Juan Luo

Theranostics· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Single-Cell Transcriptome Analysis Uncovers Intratumoral Heterogeneity and Underlying Mechanisms for Drug Resistance in Hepatobiliary Tumor Organoids.
Yan Zhao, Zhi-Xuan Li, Yan-Jing Zhu, Jing Fu, Xiao-Fang Zhao, Cheng-Jun Sui

Adv Sci (Weinh)· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Falcarindiol Enhances Cisplatin Chemosensitivity of Hepatocellular Carcinoma Down-Regulating the STAT3-Modulated PTTG1 Pathway.
Han Hong, Zhengkang Jin, Tao Qian, Xiaoyong Xu, Xiang Zhu, Chengjun Sui

Front Pharmacol· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
circFN1 Mediates Sorafenib Resistance of Hepatocellular Carcinoma Cells by Sponging miR-1205 and Regulating E2F1 Expression.
Cheng Yang, Zhitao Dong, Han Hong, Binghua Dai, Feihong Song, Chengjun Sui

Mol Ther Nucleic Acids· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trajectory and Functional Analysis of PD-1 CD4CD8 T Cells in Hepatocellular Carcinoma by Single-Cell Cytometry and Transcriptome Sequencing.
Bo Zheng, Dongfang Wang, Xinyao Qiu, Guijuan Luo, Tong Wu, Chengjun Sui

Adv Sci (Weinh)· July 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long noncoding RNA LINC00460 conduces to tumor growth and metastasis of hepatocellular carcinoma through miR-342-3p-dependent AGR2 up-regulation.
Han Hong, Chengjun Sui, Tao Qian, Xiaoyong Xu, Xiang Zhu

Aging (Albany NY)· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
LncRNA ST8SIA6-AS1 promotes hepatocellular carcinoma cell proliferation and resistance to apoptosis by targeting miR-4656/HDAC11 axis.
Qiang Fei, Feihong Song, Xinwei Jiang, Han Hong, Xiaoyong Xu, Chengjun Sui

Cancer Cell Int· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long Non-Coding RNA SNHG14 Contributes to the Development of Hepatocellular Carcinoma via Sponging miR-217.
Xiaoyong Xu, Feihong Song, Xinwei Jiang, Han Hong, Qiang Fei, Chengjun Sui

Onco Targets Ther· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Latent Risk Intrahepatic Cholangiocarcinoma Susceptible to Adjuvant Treatment After Resection: A Clinical Deep Learning Approach.
Seogsong Jeong, Yang Ge, Jing Chen, Qiang Gao, Guijuan Luo, Chengjun Sui

Front Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis